| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |